Plasma prolactin level and plasma renin activity were determined in normal subjects and patients with low and normal renin essential hypertension, renal hypertension, renovascular hypertension, primary aldosteronism, Cushing syndrome, pheochromocytoma and malignant hypertension. In both normal subjects and the normal renin essential hypertensives, plasma prolactin was significantly higher in females than in males. Plasma prolactin was also significantly higher in the normal renin essential hypertensives than in normal subjects of both sexes, while no significant difference was found between the low renin group and normal subjects of either sex. A significantly positive correlation was observed between plasma renin activity and the plasma prolactin level in male essential hypertensives, but not in females. Although no significant difference in plasma prolactin level could be detected between patients with secondary hypertension and normal subjects, this level was significantly higher in malignant hypertensives than in normotensives. Fromthese results, it was shownthat significant differences of plasma prolactin levels exist between normal renin essential hypertensives, and low renin essential hypertensives or normal subjects, and that these differences maypartly depend on renin status which might be related to the central dopaminergic activity. In malignant hypertensives, the high level of plasma prolactin may be caused by diminished renal function, but the suppression of central dopaminergic activity cannot be excluded in the mechanismof plasma prolactin increment.
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Cont rol | eHT | eHT normal subjects, and low and normal renin essential hypertensives of both sexes. In the normotensives and normal renin group, plasma prolactin levels were significantly higher in females than in males, but no sex difference was found in the low renin group. The patients with normal renin essential hypertension showed significantly higher levels than normal controls in both sexes, but those with low renin essential hypertension did not. In the comparison between normal renin group and low renin group, plasma prolactin levels were significantly higher in normal renin group than in low renin group in females, but not significantly in both renin groups in males. I « I» t amongseveral secondary hypertensives and normal controls.
On the other hand, plasma prolactin level was significantly higher in patients with malignant hypertension than in normal controls (p< 0.02). tive correlation (p < 0.02) was observed in males, but not in females.
DISCUSSION
It is well known that prolactin release is regulated primarily by the prolactin inhibiting factor (PIF)10' 11^and that domamine and its agonist stimulate PIF activity.10"13) Furthermore, it has been indicated that central dopaminergic activity may be involved in blood pressure regulation. Thus, it seems possible that plasma prolactin levels may reflect central dopaminergic activity. In the present study, a significantly higher level of plasma prolactin was observed in the patients with normal renin essential hypertension than in normal subjects of both sexes, while no difference was observed between the normal subjects and the patients with low renin essential hypertension.
These results are consistent with the data reported previously from other laboratories, 1 
